Ascentage Pharma's Full Year 2024 Financial Report Insights
Ascentage Pharma Announces Upcoming Financial Results
Ascentage Pharma, a leading global biopharmaceutical company, is set to unveil its financial results for the year 2024. The announcement is scheduled for March 27, 2025, bringing attention to its ongoing commitment to addressing unmet medical needs, particularly in hematological malignancies. The company, which operates under the stock tickers NASDAQ: AAPG and HKEX: 6855, aims to engage stakeholders through a comprehensive update during this pivotal moment.
Inviting Analysts and Investors
The management team of Ascentage Pharma welcomes analysts and investors to join them for a detailed conference call. This event will allow participants to delve into the company’s recent developments and financial performance, fostering a dialogue through a Q&A session. The call will take place at 8:00 AM Eastern Daylight Time (EDT) on March 27, making it accessible for both Eastern US and Hong Kong audiences.
Accessing the Conference Call
For those interested in attending the call, registration is a must. Attendees will gain access to a toll-free number and personal pin, ensuring they can participate seamlessly. Additionally, the call will be available via an audio webcast, allowing for broader accessibility. Ascentage Pharma’s dedication to transparency is evident in their provision of multiple avenues for stakeholder engagement.
Chinese Investor Event
Following the financial results conference call, Ascentage Pharma will host a special Mandarin investor event on March 28, 2025, at 9:30 AM Hong Kong Time (HKT). This initiative showcases the company’s commitment to its Chinese-speaking stakeholders, providing an opportunity for them to also engage with the management team through another platform.
Webcast Replay Availability
Understanding that not everyone may be able to attend the live events, Ascentage Pharma will archive the webcast replay for both the English and Mandarin calls. This replay will be accessible on the company’s corporate website for a duration of 30 days, enabling stakeholders to catch up on discussions and insights at their convenience.
About Ascentage Pharma
Since its inception, Ascentage Pharma has focused on creating innovative therapies that meet critical medical needs across various conditions, with a strong emphasis on hematological cancers. With a presence on the Hong Kong Stock Exchange since October 2019 and a recent listing on NASDAQ under the ticker AAPG, the company continues to expand its reach and impact in the biopharmaceutical sector.
Contact Information
For further inquiries regarding Ascentage Pharma, stakeholders can reach out to:
Investor Relations
Hogan Wan, Head of IR and Strategy
Hogan.Wan@ascentage.com
+86 512 85557777
Stephanie Carrington
ICR Healthcare
Stephanie.Carrington@icrhealthcare.com
(646) 277-1282
Media Relations
Sean Leous
ICR Healthcare
Sean.Leous@icrhealthcare.com
(646) 866-4012
Frequently Asked Questions
When will Ascentage Pharma's financial results be announced?
The financial results for the year 2024 will be announced on March 27, 2025.
What will be included in the conference call?
The conference call will cover the financial performance of the company and recent developments in detail.
How can I join the English conference call?
To join, you will need to register in advance to receive the necessary dial-in information and pin.
Is there a Mandarin version of the investor event?
Yes, a Mandarin investor event will take place on March 28, 2025.
Where can I access the webcast replay?
The webcast replay will be available on Ascentage Pharma’s corporate website for 30 days post-event.
About The Author
Contact Thomas Cooper privately here. Or send an email with ATTN: Thomas Cooper as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.
